Literature DB >> 8172709

Magnetic resonance imaging-enhancing lesions of the labyrinth and facial nerve. Clinical correlation.

D F Wilson1, J M Talbot, R S Hodgson.   

Abstract

OBJECTIVE: Gadolinium-enhanced magnetic resonance imaging (MRI) is useful in assessing inflammatory and neoplastic lesions of the labyrinth and facial nerve. The following cases demonstrate the ability of MRI to differentiate neoplastic from inflammatory lesions within the labyrinth. PATIENTS OR OTHER PARTICIPANTS: Nine patients were selected with enhancing lesions of the labyrinth and the facial nerve identified on MRI. INTERVENTION: Acyclovir and prednisone were prescribed for herpes zoster oticus; surgical removal of neoplastic lesions was performed. MAIN OUTCOME MEASURE: The hypothesis was developed in the course of clinical practice. No planned outcome was emphasized, as this article is based on the differential diagnoses of the cases reported.
RESULTS: Gadolinium-enhanced MRI is useful in differentiating neoplastic from inflammatory lesions within the labyrinth. Axial and coronal 3-mm sections with gadolinium enhancement were necessary for identifying these lesions and particularly for recognizing the sharp enhancement of the neoplastic margin in contrast to the dull cloudy margins of an inflammatory lesion.
CONCLUSIONS: The MRI differentiation of these lesions is helpful in providing appropriate medical and surgical management of neoplastic and inflammatory lesions of the labyrinth.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172709     DOI: 10.1001/archotol.1994.01880290070012

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  2 in total

1.  MRI of the facial nerve in idiopathic facial palsy.

Authors:  I Saatçi; F Sahintürk; L Sennaroğlu; F Boyvat; B Gürsel; A Besim
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

2.  MRI With Gadolinium as a Measure of Blood-Labyrinth Barrier Integrity in Patients With Inner Ear Symptoms: A Scoping Review.

Authors:  Christopher I Song; Jacob M Pogson; Nicholas S Andresen; Bryan K Ward
Journal:  Front Neurol       Date:  2021-05-20       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.